Clarity Pharmaceuticals Ltd

ASX:CU6 Stock Report

Market Cap: AU$797.0m

Clarity Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

Clarity Pharmaceuticals has a total shareholder equity of A$53.1M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$58.2M and A$5.1M respectively.

Key information

0%

Debt to equity ratio

AU$0

Debt

Interest coverage ration/a
CashAU$37.98m
EquityAU$53.06m
Total liabilitiesAU$5.11m
Total assetsAU$58.17m

Recent financial health updates

Recent updates

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Jan 03
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

May 29
We're Interested To See How Clarity Pharmaceuticals (ASX:CU6) Uses Its Cash Hoard To Grow

Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Aug 24
Companies Like Clarity Pharmaceuticals (ASX:CU6) Are In A Position To Invest In Growth

Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

Jan 13
Here's Why We're Not Too Worried About Clarity Pharmaceuticals' (ASX:CU6) Cash Burn Situation

Financial Position Analysis

Short Term Liabilities: CU6's short term assets (A$57.6M) exceed its short term liabilities (A$4.9M).

Long Term Liabilities: CU6's short term assets (A$57.6M) exceed its long term liabilities (A$217.7K).


Debt to Equity History and Analysis

Debt Level: CU6 is debt free.

Reducing Debt: CU6 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CU6 has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: CU6 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 42.4% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.